Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects

Richard Santen, Ercole Cavalieri, Eleanor Rogan, Jose Russo, Joseph Guttenplan, James Ingle, Wei Yue

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Abstract

Long-term exposure to estrogens influences the development of breast cancer in women, but the precise mechanisms involved are not clearly defined. Our working hypothesis is that estrogen modulates this process by two separate processes. One involves the binding of estradiol to estrogen receptor (ER) alpha with stimulation of cell proliferation. Errors in DNA occurring during replication result in fixed mutations when not repaired. The other process results from the formation of genotoxic metabolites of estradiol, which can bind to DNA, cause depurination, and result in mutations. Our collaborative group, funded by a Department of Defense Center of Excellence grant, has examined this hypothesis using a variety of experimental methods. Estradiol and its catechol-estrogen metabolite 4-OH-estradiol causes mutations in cell culture systems and can transform benign MCF-10F cells, allowing them to cause tumors in SCID mice. We have demonstrated loss of heterozygosity and gains and losses of DNA segments by comparative genomic hybridization methodology. The depurinated estradiol-guanine and -adenine adducts are measurable in MCF-7 breast cancer cells in culture and in mouse mammary tissue. The double transgenic, alpha estrogen receptor knockout/Wnt-1 knockin mouse model allows us to dissect out the separate effects of ER-mediated and ER-independent actions of estradiol. Knock out of the ER alpha delays the onset of breast tumors in this model, demonstrating a role of receptor-mediated actions. Oophorectomy delays the onset of tumors and reduces overall incidence, providing evidence for an ER-independent effect. Taken together, these data suggest that both ER-dependent and genotoxic ER-independent effects of estradiol mediate breast cancer development.

Original languageEnglish (US)
Title of host publicationSteroid Enzymes and Cancer
Pages132-140
Number of pages9
Volume1155
DOIs
StatePublished - Feb 2009

Publication series

NameAnnals of the New York Academy of Sciences
Volume1155
ISSN (Print)00778923
ISSN (Electronic)17496632

Fingerprint

Estrogen Receptors
Tumors
Estradiol
Estrogens
Breast Neoplasms
Estrogen Receptor alpha
Metabolites
Cell culture
Mutation
DNA
Cell Culture Techniques
Catechol Estrogens
Comparative Genomic Hybridization
SCID Mice
Organized Financing
Loss of Heterozygosity
Cell proliferation
Guanine
Ovariectomy
Adenine

Keywords

  • 4-OH-estradiol
  • Breast cancer
  • Estrogen
  • Genotoxicity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Santen, R., Cavalieri, E., Rogan, E., Russo, J., Guttenplan, J., Ingle, J., & Yue, W. (2009). Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. In Steroid Enzymes and Cancer (Vol. 1155, pp. 132-140). (Annals of the New York Academy of Sciences; Vol. 1155). https://doi.org/10.1111/j.1749-6632.2008.03685.x

Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. / Santen, Richard; Cavalieri, Ercole; Rogan, Eleanor; Russo, Jose; Guttenplan, Joseph; Ingle, James; Yue, Wei.

Steroid Enzymes and Cancer. Vol. 1155 2009. p. 132-140 (Annals of the New York Academy of Sciences; Vol. 1155).

Research output: Chapter in Book/Report/Conference proceedingConference contribution

Santen, R, Cavalieri, E, Rogan, E, Russo, J, Guttenplan, J, Ingle, J & Yue, W 2009, Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. in Steroid Enzymes and Cancer. vol. 1155, Annals of the New York Academy of Sciences, vol. 1155, pp. 132-140. https://doi.org/10.1111/j.1749-6632.2008.03685.x
Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J et al. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. In Steroid Enzymes and Cancer. Vol. 1155. 2009. p. 132-140. (Annals of the New York Academy of Sciences). https://doi.org/10.1111/j.1749-6632.2008.03685.x
Santen, Richard ; Cavalieri, Ercole ; Rogan, Eleanor ; Russo, Jose ; Guttenplan, Joseph ; Ingle, James ; Yue, Wei. / Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects. Steroid Enzymes and Cancer. Vol. 1155 2009. pp. 132-140 (Annals of the New York Academy of Sciences).
@inproceedings{d6912c47f3bd48778cd476d4918fb4f3,
title = "Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects",
abstract = "Long-term exposure to estrogens influences the development of breast cancer in women, but the precise mechanisms involved are not clearly defined. Our working hypothesis is that estrogen modulates this process by two separate processes. One involves the binding of estradiol to estrogen receptor (ER) alpha with stimulation of cell proliferation. Errors in DNA occurring during replication result in fixed mutations when not repaired. The other process results from the formation of genotoxic metabolites of estradiol, which can bind to DNA, cause depurination, and result in mutations. Our collaborative group, funded by a Department of Defense Center of Excellence grant, has examined this hypothesis using a variety of experimental methods. Estradiol and its catechol-estrogen metabolite 4-OH-estradiol causes mutations in cell culture systems and can transform benign MCF-10F cells, allowing them to cause tumors in SCID mice. We have demonstrated loss of heterozygosity and gains and losses of DNA segments by comparative genomic hybridization methodology. The depurinated estradiol-guanine and -adenine adducts are measurable in MCF-7 breast cancer cells in culture and in mouse mammary tissue. The double transgenic, alpha estrogen receptor knockout/Wnt-1 knockin mouse model allows us to dissect out the separate effects of ER-mediated and ER-independent actions of estradiol. Knock out of the ER alpha delays the onset of breast tumors in this model, demonstrating a role of receptor-mediated actions. Oophorectomy delays the onset of tumors and reduces overall incidence, providing evidence for an ER-independent effect. Taken together, these data suggest that both ER-dependent and genotoxic ER-independent effects of estradiol mediate breast cancer development.",
keywords = "4-OH-estradiol, Breast cancer, Estrogen, Genotoxicity",
author = "Richard Santen and Ercole Cavalieri and Eleanor Rogan and Jose Russo and Joseph Guttenplan and James Ingle and Wei Yue",
year = "2009",
month = "2",
doi = "10.1111/j.1749-6632.2008.03685.x",
language = "English (US)",
isbn = "9781573317450",
volume = "1155",
series = "Annals of the New York Academy of Sciences",
pages = "132--140",
booktitle = "Steroid Enzymes and Cancer",

}

TY - GEN

T1 - Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects

AU - Santen, Richard

AU - Cavalieri, Ercole

AU - Rogan, Eleanor

AU - Russo, Jose

AU - Guttenplan, Joseph

AU - Ingle, James

AU - Yue, Wei

PY - 2009/2

Y1 - 2009/2

N2 - Long-term exposure to estrogens influences the development of breast cancer in women, but the precise mechanisms involved are not clearly defined. Our working hypothesis is that estrogen modulates this process by two separate processes. One involves the binding of estradiol to estrogen receptor (ER) alpha with stimulation of cell proliferation. Errors in DNA occurring during replication result in fixed mutations when not repaired. The other process results from the formation of genotoxic metabolites of estradiol, which can bind to DNA, cause depurination, and result in mutations. Our collaborative group, funded by a Department of Defense Center of Excellence grant, has examined this hypothesis using a variety of experimental methods. Estradiol and its catechol-estrogen metabolite 4-OH-estradiol causes mutations in cell culture systems and can transform benign MCF-10F cells, allowing them to cause tumors in SCID mice. We have demonstrated loss of heterozygosity and gains and losses of DNA segments by comparative genomic hybridization methodology. The depurinated estradiol-guanine and -adenine adducts are measurable in MCF-7 breast cancer cells in culture and in mouse mammary tissue. The double transgenic, alpha estrogen receptor knockout/Wnt-1 knockin mouse model allows us to dissect out the separate effects of ER-mediated and ER-independent actions of estradiol. Knock out of the ER alpha delays the onset of breast tumors in this model, demonstrating a role of receptor-mediated actions. Oophorectomy delays the onset of tumors and reduces overall incidence, providing evidence for an ER-independent effect. Taken together, these data suggest that both ER-dependent and genotoxic ER-independent effects of estradiol mediate breast cancer development.

AB - Long-term exposure to estrogens influences the development of breast cancer in women, but the precise mechanisms involved are not clearly defined. Our working hypothesis is that estrogen modulates this process by two separate processes. One involves the binding of estradiol to estrogen receptor (ER) alpha with stimulation of cell proliferation. Errors in DNA occurring during replication result in fixed mutations when not repaired. The other process results from the formation of genotoxic metabolites of estradiol, which can bind to DNA, cause depurination, and result in mutations. Our collaborative group, funded by a Department of Defense Center of Excellence grant, has examined this hypothesis using a variety of experimental methods. Estradiol and its catechol-estrogen metabolite 4-OH-estradiol causes mutations in cell culture systems and can transform benign MCF-10F cells, allowing them to cause tumors in SCID mice. We have demonstrated loss of heterozygosity and gains and losses of DNA segments by comparative genomic hybridization methodology. The depurinated estradiol-guanine and -adenine adducts are measurable in MCF-7 breast cancer cells in culture and in mouse mammary tissue. The double transgenic, alpha estrogen receptor knockout/Wnt-1 knockin mouse model allows us to dissect out the separate effects of ER-mediated and ER-independent actions of estradiol. Knock out of the ER alpha delays the onset of breast tumors in this model, demonstrating a role of receptor-mediated actions. Oophorectomy delays the onset of tumors and reduces overall incidence, providing evidence for an ER-independent effect. Taken together, these data suggest that both ER-dependent and genotoxic ER-independent effects of estradiol mediate breast cancer development.

KW - 4-OH-estradiol

KW - Breast cancer

KW - Estrogen

KW - Genotoxicity

UR - http://www.scopus.com/inward/record.url?scp=61649123555&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=61649123555&partnerID=8YFLogxK

U2 - 10.1111/j.1749-6632.2008.03685.x

DO - 10.1111/j.1749-6632.2008.03685.x

M3 - Conference contribution

SN - 9781573317450

VL - 1155

T3 - Annals of the New York Academy of Sciences

SP - 132

EP - 140

BT - Steroid Enzymes and Cancer

ER -